Cargando…
Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
Passive immunization with antibodies has been shown to prevent a wide variety of diseases. Recent advances in monoclonal antibody technology are enabling the development of new methods for passive immunization of mucosal surfaces. Human monoclonal antibodies, produced rapidly, inexpensively, and in...
Autores principales: | Zeitlin, L, Cone, R A, Whaley, K J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627706/ https://www.ncbi.nlm.nih.gov/pubmed/10081672 |
Ejemplares similares
-
Engineering monoclonal antibody-based contraception and multipurpose prevention technologies(†)
por: Anderson, Deborah J, et al.
Publicado: (2020) -
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
por: Whaley, Kevin J, et al.
Publicado: (2021) -
Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
por: Castilho, Alexandra, et al.
Publicado: (2011) -
Engineering the supernatural: monoclonal antibodies for
challenging infectious diseases
por: Grace, Patricia S, et al.
Publicado: (2022) -
A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication
por: Rong, Yinghui, et al.
Publicado: (2020)